We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Medicines Company | NASDAQ:MDCO | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 84.90 | 84.00 | 84.94 | 0 | 01:00:00 |
From May 2019 to May 2024
The Medicines Company (NASDAQ:MDCO) will host a conference call on Wednesday, April 26, 2017, at 8:30 a.m., Eastern Daylight Time, to discuss first-quarter 2017 financial results and operational developments.
The dial-in information to access the call is listed below:
U.S./Canada: (877) 359-9508International: (224) 357-2393Conference ID: 4094876
A taped replay of the conference call will be available from 11:30 a.m., Eastern Daylight Time, following the conference call until 11:30 a.m., Eastern Daylight Time, on May 3, 2017. The replay may be accessed as follows:
U.S./Canada: (855) 859-2056International: (404) 537-3406Conference ID: 4094876
The webcast can be accessed in the Investors section of The Medicines Company website. A replay of the webcast will also be available.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by an overriding purpose — to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170412005836/en/
The Medicines CompanyMediaMeg Langan, 973-290-6319Vice Presidentmargaret.langan@themedco.comorInvestor RelationsKrishna Gorti, M.D., 973-290-6122Vice President, Investor Relationskrishna.gorti@themedco.com
1 Year Medicines Chart |
1 Month Medicines Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
